Optimizing respiratory care: clinical pharmacist interventions in respiratory tract infection management at a tertiary teaching hospital.

IF 1.1 Q4 RESPIRATORY SYSTEM
Chandrashekhar Mallikarjun Patil, Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Vinod Ashok Koujalagi, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud
{"title":"Optimizing respiratory care: clinical pharmacist interventions in respiratory tract infection management at a tertiary teaching hospital.","authors":"Chandrashekhar Mallikarjun Patil, Princy Domnic Dsouza, Sai Phalguna Prakash Chitralu, Vinod Ashok Koujalagi, Agadi Hiremath Viswanatha Swamy, Sanatkumar Bharamu Nyamagoud","doi":"10.4081/monaldi.2025.3337","DOIUrl":null,"url":null,"abstract":"<p><p>Respiratory tract infections (RTIs) are prevalent in India, affecting approximately 11.3% of the population. India leads globally in lung disease mortality, including chronic obstructive pulmonary disease and asthma, contributing significantly to disability-adjusted life years and mortality rates. The role of clinical pharmacist interventions (CPIs) in optimizing antibiotic use and managing RTIs is increasingly recognized as vital for improving patient outcomes and reducing healthcare costs. This study aimed to evaluate the effectiveness of CPIs in managing RTIs among inpatients at Vivekananda General Hospital, Hubballi, and to identify common drug-related problems (DRPs) using the Hepler-Strand classification system. A cross-sectional study was conducted over 6 months, including 200 inpatients diagnosed with RTIs. Data was collected through patient profiles, treatment charts, and medical case sheets. The study employed descriptive and inferential statistical analyses to evaluate the impact of CPIs on antibiotic therapy and the prevalence of DRPs. The study identified drug-drug interactions as the most frequent DRP (38.30%), followed by drug duplication (31.49%) and improper drug selection (9.79%). Other issues included adverse drug reactions (4.68%), overdosage (5.53%), untreated indications (6.38%), subtherapeutic dosage (2.13%), and drug use without indication (1.70%). CPIs, including prospective audits, prescription feedback, and healthcare professional education, effectively addressed these issues, improved antibiotic appropriateness, and optimized patient outcomes. CPIs significantly enhance the management of RTIs by addressing various DRPs and optimizing antibiotic use. The study underscores the importance of incorporating pharmacists into antimicrobial stewardship programs to improve medication safety, efficacy, and overall patient care in managing RTIs. Continued emphasis on pharmacist-led interventions and adherence to best practices in antimicrobial stewardship is essential for reducing the burden of respiratory diseases in India.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Monaldi Archives for Chest Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/monaldi.2025.3337","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Respiratory tract infections (RTIs) are prevalent in India, affecting approximately 11.3% of the population. India leads globally in lung disease mortality, including chronic obstructive pulmonary disease and asthma, contributing significantly to disability-adjusted life years and mortality rates. The role of clinical pharmacist interventions (CPIs) in optimizing antibiotic use and managing RTIs is increasingly recognized as vital for improving patient outcomes and reducing healthcare costs. This study aimed to evaluate the effectiveness of CPIs in managing RTIs among inpatients at Vivekananda General Hospital, Hubballi, and to identify common drug-related problems (DRPs) using the Hepler-Strand classification system. A cross-sectional study was conducted over 6 months, including 200 inpatients diagnosed with RTIs. Data was collected through patient profiles, treatment charts, and medical case sheets. The study employed descriptive and inferential statistical analyses to evaluate the impact of CPIs on antibiotic therapy and the prevalence of DRPs. The study identified drug-drug interactions as the most frequent DRP (38.30%), followed by drug duplication (31.49%) and improper drug selection (9.79%). Other issues included adverse drug reactions (4.68%), overdosage (5.53%), untreated indications (6.38%), subtherapeutic dosage (2.13%), and drug use without indication (1.70%). CPIs, including prospective audits, prescription feedback, and healthcare professional education, effectively addressed these issues, improved antibiotic appropriateness, and optimized patient outcomes. CPIs significantly enhance the management of RTIs by addressing various DRPs and optimizing antibiotic use. The study underscores the importance of incorporating pharmacists into antimicrobial stewardship programs to improve medication safety, efficacy, and overall patient care in managing RTIs. Continued emphasis on pharmacist-led interventions and adherence to best practices in antimicrobial stewardship is essential for reducing the burden of respiratory diseases in India.

优化呼吸系统护理:一家三级教学医院呼吸道感染管理中的临床药剂师干预措施。
呼吸道感染(RTIs)在印度很普遍,影响了大约11.3%的人口。印度在包括慢性阻塞性肺病和哮喘在内的肺病死亡率方面居全球首位,对残疾调整后的寿命年数和死亡率有重大贡献。临床药师干预(CPIs)在优化抗生素使用和管理RTIs中的作用越来越被认为是改善患者预后和降低医疗成本的关键。本研究旨在评估CPIs在管理Hubballi Vivekananda总医院住院患者rti中的有效性,并使用Hepler-Strand分类系统识别常见的药物相关问题(DRPs)。一项为期6个月的横断面研究,包括200名诊断为RTIs的住院患者。通过患者简介、治疗图表和医疗病例表收集数据。本研究采用描述性和推断性统计分析来评估cpi对抗生素治疗和DRPs患病率的影响。研究发现,药物相互作用是最常见的DRP(38.30%),其次是药物重复(31.49%)和药物选择不当(9.79%)。其他问题包括药物不良反应(4.68%)、用药过量(5.53%)、适应症未治疗(6.38%)、亚治疗剂量(2.13%)和无适应症用药(1.70%)。cpi,包括前瞻性审计、处方反馈和医疗保健专业教育,有效地解决了这些问题,改善了抗生素的适宜性,并优化了患者的预后。cpi通过解决各种drp和优化抗生素使用,显著加强了RTIs的管理。该研究强调了将药剂师纳入抗菌药物管理计划的重要性,以提高药物安全性、有效性和管理rti的整体患者护理。继续强调药剂师主导的干预措施和遵守抗微生物药物管理方面的最佳做法,对于减轻印度呼吸道疾病的负担至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
1
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信